Patents by Inventor Mark John ANDERTON

Mark John ANDERTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250064967
    Abstract: A pharmaceutical product for administration of an anti TROP2 antibody-drug conjugate in combination with an ATR inhibitor is provided. The anti-TROP2 antibody-drug conjugate is an antibody-drug conjugate in which a drug linker represented by the following formula (wherein A represents the connecting position to an anti-TROP2 antibody) is conjugated to an anti-TROP2 antibody via a thioether bond. Also provided is a therapeutic use and method wherein the anti-TROP2 antibody-drug conjugate and the ATR inhibitor are administered in combination to a subject: Formula (I).
    Type: Application
    Filed: December 27, 2022
    Publication date: February 27, 2025
    Applicants: AstraZeneca UK Limited, DAIICHI SANKYO COMPANY , LIMITED
    Inventors: Matthew Simon SUNG, Alan Yin Kai LAU, Yann WALLEZ, Jerome Thomas METTETAL, II, Theresa Angela PROIA, Suzanne Jane RANDLE, Mark John ANDERTON